Letter: The feasibility and safety of accelerated infliximab infusions in patients with inflammatory bowel disease

Aliment Pharmacol Ther. 2014 Feb;39(4):444-5. doi: 10.1111/apt.12607.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal / administration & dosage*
  • Antirheumatic Agents / administration & dosage*
  • Arthritis, Rheumatoid / drug therapy*
  • Gastrointestinal Agents / administration & dosage*
  • Humans
  • Inflammatory Bowel Diseases / drug therapy*
  • Spondylarthropathies / drug therapy*

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Gastrointestinal Agents